Bortezomib induced subconjunctival hemorrhage

Navin Patil, Ommurugan Balaji, Karthik S. Udupa, Karthik Rao

Research output: Contribution to journalArticlepeer-review


Many drugs are used in the treatment of multiple myeloma but thalidomide, lenalidomide, bortezomib, and dexamethasone and their combination remain the main stay of treatment. The molecular formula of bortezomib is C19H25BN4O4 and its chemical name is (3-methyl-1-(3-phenyl-2-pyrazin-2-ylcarbonylamino-propanoyl) amino-butyl) boronic acid. Mechanisms by which it acts is usually by 26 SProteasome inhibition leading to degradation of anti-apoptotic proteins. Bortezomib is known to cause many side effects. Hence, we report a rare case of bortezomib-induced subconjunctival hemorrhage in our tertiary care hospital.

Original languageEnglish
Pages (from-to)10-11
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Issue number4
Publication statusPublished - 01-04-2017

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)


Dive into the research topics of 'Bortezomib induced subconjunctival hemorrhage'. Together they form a unique fingerprint.

Cite this